$KOPN
KOPIN CORP Stock $kopn

$kopn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019194 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2
Revenue	$234.3K	$207.3K	$473.5K
YoY Change	-50.51%		-96.02%
Cost Of Revenue	$8.685M	$8.542M	$6.624M
YoY Change	31.12%		-16.22%
Gross Profit	$3.651M	$1.491M	$4.134M
YoY Change	-11.68%		3.28%
Gross Profit Margin	1558.14%	719.25%	873.09%
Selling, General & Admin	$7.268M	$7.232M	$4.648M
YoY Change	56.36%		7.41%
% of Gross Profit	199.06%	485.01%	112.43%
Research & Development	$1.840M	$2.101M	$2.312M
YoY Change	-20.44%		-55.06%
% of Gross Profit	50.39%	140.89%	55.93%
Depreciation & Amortization	$136.8K	$195.4K	$224.6K
YoY Change	-39.1%		-16.1%
% of Gross Profit	3.75%	13.1%	5.43%
Operating Expenses	$17.79M	$42.67M	$13.58M
YoY Change	30.98%		-21.83%
Operating Profit	-$5.456M	-$32.64M	-$2.826M
YoY Change	93.06%		-48.33%
Interest Expense	-$484.4K	$93.38K	$199.7K
YoY Change	-342.62%		-245.17%
% of Operating Profit
Other Income/Expense, Net	-$465.6K	$93.34K	$236.7K
YoY Change	-296.69%		-267.72%
Pretax Income	-$5.922M	-$32.55M	-$2.590M
YoY Change	128.69%		-53.85%
Income Tax			$39.00K
% Of Pretax Income
Net Earnings	-$5.922M	-$32.50M	-$2.629M
YoY Change	125.29%		-53.45%
Net Earnings / Revenue	-2527.28%	-15677.01%	-555.13%
Basic Earnings Per Share	-$0.05	-$0.27	-$0.03
Diluted Earnings Per Share	-$0.05	-$0.27	-$0.03
COMMON SHARES
Basic Shares Outstanding	118.4M shares	118.4M shares	105.0M shares
Diluted Shares Outstanding	121.4M shares	120.1M shares	105.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.63M	$21.06M	$29.61M
YoY Change	-40.46%		59.55%
Cash & Equivalents	$10.04M	$14.12M	$8.583M
Short-Term Investments	$7.587M	$6.941M	$21.03M
Other Short-Term Assets	$3.111M	$2.320M	$1.712M
YoY Change	81.74%		-24.3%
Inventory	$5.650M	$6.120M	$6.818M
Prepaid Expenses
Receivables	$7.406M	$6.802M	$5.613M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$40.32M	$41.99M	$46.80M
YoY Change	-13.84%		16.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.143M	$2.213M	$1.826M
YoY Change	17.37%		5.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.982M	$4.612M	$7.728M
YoY Change	-48.47%		-21.4%
Other Assets	$124.9K	$124.9K	$169.1K
YoY Change	-26.14%		-1.05%
Total Long-Term Assets	$8.728M	$9.277M	$12.73M
YoY Change	-31.43%		-17.92%
TOTAL ASSETS
Total Short-Term Assets	$40.32M	$41.99M	$46.80M
Total Long-Term Assets	$8.728M	$9.277M	$12.73M
Total Assets	$49.05M	$51.27M	$59.52M
YoY Change	-17.6%		7.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.714M	$8.994M	$3.836M
YoY Change	48.93%		-21.07%
Accrued Expenses	$13.42M	$6.055M	$5.854M
YoY Change	129.22%		1.73%
Deferred Revenue	$198.3K	$886.4K	$718.5K
YoY Change	-72.4%		-76.42%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.35M	$42.51M	$11.75M
YoY Change	285.86%		-21.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.494M	$1.494M	$1.361M
YoY Change	9.76%		-32.48%
Total Long-Term Liabilities	$1.494M	$1.494M	$1.361M
YoY Change	9.76%		-32.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.35M	$42.51M	$11.75M
Total Long-Term Liabilities	$1.494M	$1.494M	$1.361M
Total Liabilities	$49.26M	$46.33M	$16.63M
YoY Change	196.29%		-17.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$396.6M	-$390.7M	-$341.0M
YoY Change	16.3%		4.58%
Common Stock	$1.156M	$1.154M	$1.100M
YoY Change	5.16%		19.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$103.1K	$103.1K	$103.1K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	-$216.3K	$4.940M	$42.90M
YoY Change
Total Liabilities & Shareholders Equity	$49.05M	$51.27M	$59.52M
YoY Change	-17.6%		7.11%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q2
OPERATING ACTIVITIES
Net Income	-$5.922M	-$32.50M	-$2.629M
YoY Change	125.29%		-53.45%
Depreciation, Depletion And Amortization	$136.8K	$195.4K	$224.6K
YoY Change	-39.1%		-16.1%
Cash From Operating Activities	-$3.077M	-$3.100M	-$4.175M
YoY Change	-26.29%		-54.4%
INVESTING ACTIVITIES
Capital Expenditures	$65.17K	$245.4K	$216.6K
YoY Change	-69.91%		-368.86%
Acquisitions
YoY Change
Other Investing Activities	-$639.0K		-$1.000K
YoY Change	63800.0%		-99.9%
Cash From Investing Activities	-$704.2K	$4.525M	-$16.84M
YoY Change	-95.82%		1464.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$7.300M	$21.34M
YoY Change		-65.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$7.243M	$21.34M
YoY Change	-100.0%		952.49%
NET CHANGE
Cash From Operating Activities	-3.077M	-$3.100M	-$4.175M
Cash From Investing Activities	-704.2K	$4.525M	-$16.84M
Cash From Financing Activities	0.000	$7.243M	$21.34M
Net Change In Cash	-3.781M	$8.658M	$324.3K
YoY Change	-1266.05%		-103.95%
FREE CASH FLOW
Cash From Operating Activities	-$3.077M	-$3.100M	-$4.175M
Capital Expenditures	$65.17K	$245.4K	$216.6K
Free Cash Flow	-$3.142M	-$3.345M	-$4.391M
YoY Change	-28.44%		-51.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000771266
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination		usd
CY2024Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2024Q1	KOPN	Increase Decrease In Provision For Credit Losses IncreaseDecreaseInProvisionForCreditLosses		usd
CY2023Q2	KOPN	Increase Decrease In Accrued Litigation Damages IncreaseDecreaseInAccruedLitigationDamages		usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities		usd
CY2023Q2	KOPN	Issuance Of Common Stock Net Of Costs IssuanceOfCommonStockNetOfCosts		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	118428000	shares
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14118762	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	750000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	6941080	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	987000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1025000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6801658	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5687165	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6120355	usd
CY2024Q1	us-gaap	Prepaid Taxes PrepaidTaxes	86578	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1483049	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	41988647	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2212691	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2328152	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	124925	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4611510	usd
CY2024Q1	us-gaap	Assets Assets	51265925	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8993894	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1826176	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2160000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	886432	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628019	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	602500	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1440364	usd
CY2024Q1	us-gaap	Deposits Deposits	701777	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	470884	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	24800000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	42510046	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15878315	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	361779	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	278112	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1680063	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1832982	usd
CY2024Q1	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	279996	usd
CY2023Q4	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	319996	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1494016	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1494016	usd
CY2024Q1	us-gaap	Liabilities Liabilities	46325900	usd
CY2023Q4	us-gaap	Liabilities Liabilities	19803421	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	118498635	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	114253818	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	115351480	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112251416	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1154220	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1123220	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	393358051	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	385411542	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1234130	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1232294	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-390703249	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-358155034	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	4940025	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	29508895	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51265925	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49312316	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10032641	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758191	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8541574	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6624101	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2100753	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2312217	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7231865	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4648130	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	24800000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	42674192	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13584448	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-32641551	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2826257	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	172840	usd
CY2023Q2	us-gaap	Interest Income Operating InterestIncomeOperating	101765	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-43	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37030	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-79461	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	97907	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	93336	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	236702	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32548215	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2589555	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-32548215	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2628555	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120114985	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120114985	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105036382	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105036382	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-32548215	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2628555	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6300000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2024Q1	us-gaap	Extended Product Warranty Description ExtendedProductWarrantyDescription	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2160000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	177600	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	177600	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2160000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0.0	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122700000	usd
CY2024Q1	KOPN	Operating Loss Carryforwards Expiring Date OperatingLossCarryforwardsExpiringDate	expiring 2024 through 2038
CY2024Q1	KOPN	Operating Loss Carryforwards Unlimited OperatingLossCarryforwardsUnlimited	116200000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5687165	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3409809	usd
CY2024Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	2277356	usd
CY2024Q1	KOPN	Percentage Of Change In Contract Assets Current PercentageOfChangeInContractAssetsCurrent	0.67	pure
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2204	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9994	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4040	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3767	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1836	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6227	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32546379	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2622328	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	194190	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6227	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21335000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21335000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42897477	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42897477	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-32548215	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	195399	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	224574	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	734928	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	194190	usd
CY2023Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	39105	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-66132	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	118697	usd
CY2023Q2	KOPN	Increase Decrease In Provision For Credit Losses IncreaseDecreaseInProvisionForCreditLosses	495000	usd
CY2024Q1	KOPN	Noncash Provision For Excess Inventory NoncashProvisionForExcessInventory	771580	usd
CY2023Q2	KOPN	Noncash Provision For Excess Inventory NoncashProvisionForExcessInventory	292405	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-184	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3082659	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	420919	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2177260	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-934759	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-694949	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	665589	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	366540	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	525705	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1682980	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1983304	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-43746	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-211815	usd
CY2024Q1	KOPN	Increase Decrease In Accrued Litigation Damages IncreaseDecreaseInAccruedLitigationDamages	24800000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3106950	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4174551	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	245429	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	216618	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	230012	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17624779	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5000060	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1000000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4524619	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16840397	usd
CY2024Q1	KOPN	Issuance Of Common Stock Net Of Costs IssuanceOfCommonStockNetOfCosts	7242581	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21335000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7242581	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21335000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2173	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4216	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8658077	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	324268	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6210685	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8258878	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14868762	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8583146	usd
CY2024Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_804_eus-gaap--BasisOfAccounting_zZyrilYNoDE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_829_zPbUyCvDd5xf">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of March 30, 2024 and for the three month periods ended March 30, 2024 and April 1, 2023 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements for the three month periods ended March 30, 2024 and April 1, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231230_zlIXs1d1Q6Tj" title="Net losses">19.6</span> million and net cash outflows from operations of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231230_zuv1Ir86J0Zf" title="Net cash outflows from operations">15.3</span> million for the fiscal year ended 2023. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240330_zw6UGAtUt9Lk" title="Net losses">32.5</span> million for the three months ended March 30, 2024 and net cash outflows from operations of $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20231231__20240330_zihgtQomy9M5" title="Net cash outflows from operations">3.1</span> million. This net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240330_zEGjaxFULlH9" title="Net losses">32.5</span> million includes an estimated $<span id="xdx_901_ecustom--EstimatedPossibleDamagesAmount_pn5n6_c20231231__20240330_zoxMjLG2vgJa" title="Estimated possible damages amount">24.8</span> million of possible damages related to a jury verdict which is explained below. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses. As described in Note 14 Litigation, on April 22, 2024, a jury verdict was entered against the Company awarding approximately $<span id="xdx_90D_eus-gaap--LitigationSettlementLoss_pn5n6_c20240422__20240422_zLB7tLN3y0F5" title="Damages settlement">5.1</span> million in damages as well as recommending $<span id="xdx_908_eus-gaap--PaymentsForLegalSettlements_pn5n6_c20240422__20240422_zdLeCcxClsbc" title="Exemplary damages">19.7</span> million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. The Company plans to argue that the damages, disgorgement and exemplary damages should be reduced or eliminated. The Company is also considering the appeal of any award in a final judgment. The Company had $<span id="xdx_904_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20240330_zFmCyCNh50H3" title="Cash and cash equivalents, restricted cash, and marketable debt securities">21.8</span> million of cash and cash equivalents, restricted cash, and marketable debt securities at March 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historical and current negative cash flow from operations and limited liquidity resources. The Company’s current strategy is to continue to invest in its business and raise additional capital through financing activities that may include public offerings and private placements of its common stock, preferred stock offerings, collaborations and licensing arrangements and issuances of debt and convertible debt instruments. Until such time that additional capital can be raised, the Company plans to strategically manage its uncommitted spend, execute its priorities and implement cost saving measures to reduce research and development and general and administrative expenditures which could include minimizing staff costs. The Company may also sell assets and look at other strategic alternatives. There are inherent uncertainties associated with fundraising activities and activities to manage our uncommitted spending and the successful execution of these activities may not be within the Company’s control. There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company is unable to achieve positive cash flows and profitability in the foreseeable future, cannot successfully raise additional capital and implement its strategic plan, or the recommended disgorgement and exemplary damages are not significantly reduced or eliminated in the final order the Company’s liquidity, financial condition and business prospects will be materially and adversely affected. There is substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19600000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15300000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-32500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3100000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-32500000	usd
CY2024Q1	KOPN	Estimated Possible Damages Amount EstimatedPossibleDamagesAmount	24800000	usd
CY2024Q2	us-gaap	Litigation Settlement Loss LitigationSettlementLoss	5100000	usd
CY2024Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	19700000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	21800000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	800000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	7730156	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	12250204	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-39076	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-58204	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	7691080	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	12192000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	6724227	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	966853	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	7691080	usd
CY2024Q1	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	21225999	usd
CY2023Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	21960127	usd
CY2024Q1	us-gaap	Investments Investments	5200000	usd
CY2023Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	400000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
CY2023Q3	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	2500000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7788658	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	10731036	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	987000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1025000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6801658	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9706036	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1025000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	38000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	987000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3968980	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4785197	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1579838	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2018421	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	571537	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	798188	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6120355	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7601806	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3076520	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1530945	shares
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3080000	shares
CY2024Q1	KOPN	Gross Proceeds From Registered Sale Equity Securities GrossProceedsFromRegisteredSaleEquitySecurities	7466755	usd
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.42
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	200294	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1931767	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.65
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1164817	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.68
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	20064	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.91
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3076520	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.04
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	734928	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	194190	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	734928	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	194190	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6300000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	886432	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	916826	usd
CY2024Q1	us-gaap	Extended Product Warranty Description ExtendedProductWarrantyDescription	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2160000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	177600	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	177600	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0.0	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122700000	usd
CY2024Q1	KOPN	Operating Loss Carryforwards Expiring Date OperatingLossCarryforwardsExpiringDate	expiring 2024 through 2038
CY2024Q1	KOPN	Operating Loss Carryforwards Unlimited OperatingLossCarryforwardsUnlimited	116200000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5687165	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3409809	usd
CY2024Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	2277356	usd
CY2024Q1	KOPN	Percentage Of Change In Contract Assets Current PercentageOfChangeInContractAssetsCurrent	0.67	pure
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	886432	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	916826	usd
CY2024Q1	KOPN	Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract	30394	usd
CY2024Q1	KOPN	Percentage Contract Liabilities And Billings In Excess Of Revenue Earned PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned	-0.03	pure
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10080	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23198	usd
CY2024Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	13118	usd
CY2024Q1	KOPN	Percentage Of Change In Contract Liabilitiesnoncurrent PercentageOfChangeInContractLiabilitiesnoncurrent	-0.57	pure
CY2024Q1	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	4790653	usd
CY2023Q4	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	2469785	usd
CY2024Q1	KOPN	Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	2320868	usd
CY2024Q1	KOPN	Percentage Of Change In Net Contract Assets Liabilities PercentageOfChangeInNetContractAssetsLiabilities	0.94	pure
CY2024Q1	KOPN	Net Contract Assets NetContractAssets	2300000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2024Q1	KOPN	Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract	30394	usd
CY2024Q1	KOPN	Percentage Contract Liabilities And Billings In Excess Of Revenue Earned PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned	-0.03	pure
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10080	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23198	usd
CY2024Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	13118	usd
CY2024Q1	KOPN	Percentage Of Change In Contract Liabilitiesnoncurrent PercentageOfChangeInContractLiabilitiesnoncurrent	-0.57	pure
CY2024Q1	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	4790653	usd
CY2023Q4	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	2469785	usd
CY2024Q1	KOPN	Percentage Of Change In Net Contract Assets Liabilities PercentageOfChangeInNetContractAssetsLiabilities	0.94	pure
CY2024Q1	KOPN	Net Contract Assets NetContractAssets	2300000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	31100000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	227802	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	214563	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	579834	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	639078	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	604000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	604000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	201333	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2628245	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	320163	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2308082	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	31100000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	227802	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	214563	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	579834	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	639078	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	604000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	604000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	201333	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2628245	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	320163	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2308082	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628019	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1680063	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2308082	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628019	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1680063	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2308082	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	216272	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0626	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M9D
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	4541000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4668000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	4541000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4668000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10033000	usd
CY2024Q1	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2023Q2	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2024Q1	us-gaap	Revenues Revenues	207310	usd
CY2024Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	89350	usd
CY2023Q2	us-gaap	Revenues Revenues	624216	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	110038	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	93050	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	593581	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29600	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	216272	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0626	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M9D
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	4541000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4668000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	4541000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4668000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10033000	usd
CY2024Q1	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2023Q2	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10033000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2024Q2	us-gaap	Loss Contingency Damages Sought LossContingencyDamagesSought	On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues.
CY2024Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	5100000	usd
CY2024Q1	KOPN	Loss Contingency Disgorgement And Exemplary Damages LossContingencyDisgorgementAndExemplaryDamages	19700000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10033000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2024Q2	us-gaap	Loss Contingency Damages Sought LossContingencyDamagesSought	On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues.
CY2024Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	5100000	usd
CY2024Q1	KOPN	Loss Contingency Disgorgement And Exemplary Damages LossContingencyDisgorgementAndExemplaryDamages	19700000	usd
CY2024Q1	us-gaap	Revenues Revenues	207310	usd
CY2024Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	89350	usd
CY2023Q2	us-gaap	Revenues Revenues	624216	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	110038	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	593581	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29600	usd

Files In Submission

Name	View Source	Status
0001493152-24-019194-index-headers.html	Edgar Link	pending
0001493152-24-019194-index.html	Edgar Link	pending
0001493152-24-019194.txt	Edgar Link	pending
0001493152-24-019194-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kopn-20240330.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
kopn-20240330_cal.xml	Edgar Link	unprocessable
kopn-20240330_def.xml	Edgar Link	unprocessable
kopn-20240330_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kopn-20240330_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOPN
KOPIN CORP Stock $kopn

2024 Q2 Form 10-Q Financial Statement

#000149315224019194 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN KOPIN CORP Stock $kopn

2024 Q2 Form 10-Q Financial Statement

#000149315224019194 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN
KOPIN CORP Stock $kopn